Table 4.
Association between clinical-pathological parameters and distinct intervals of serum resistin concentrations.
| Parameters | Resistin | p | (Odds ratio; 95% CI) | ||
|---|---|---|---|---|---|
| ≤8,400 | >8,400 | ||||
| BF% | ≤ 25% | 23 | 0 | <0.0001* | (∞; 48.25–∞) |
| >25% | 1 | 18 | |||
| BMIc | ≤ 15.1 Kg/m2 | 23 | 15 | 0.0022* | (16.87; 2.229–188.5) |
| >15.1 Kg/m2 | 1 | 11 | |||
| Size | <5 cm | 13 | 12 | 0.7775 | (1.379; 0.4489–4.449) |
| ≥5 cm | 11 | 14 | |||
| Clinical stage | l–II | 12 | 11 | 0.7769 | (1.364; 0.4397–4.419) |
| III–IV | 12 | 15 | |||
| Histological grade | I | 16 | 11 | 0.0874 | (2.727; 0.8640–8.240) |
| II | 8 | 15 | |||
| Ki-67 | <14% | 24 | 4 | <0.0001* | (60.00; 9.803–291.3) |
| ≥14% | 2 | 20 | |||
*
Stands for significant differences at the chi-square test considering p < 0.05. BF%, % of body fat; BMIc, canine body mass index.